Risk of underlying chronic medical conditions for invasive pneumococcal disease in adults

被引：37

作者：

Baxter, Roger ^{[1
]}

Yee, Arnold ^{[1
]}

Aukes, Laurie ^{[1
]}

Snow, Vincenza ^{[2
]}

Fireman, Bruce ^{[1
]}

Atkinson, Bruce ^{[2
]}

Klein, Nicola P. ^{[1
]}

机构：

[1] Kaiser Permanente Northern Calif, Vaccine Study Ctr, Oakland, CA USA

[2] Pfizer Vaccines, 500 Arcola Rd, Collegeville, PA USA

来源：

VACCINE | 2016年 / 34卷 / 36期

关键词：

Pneumococcal; Streptococcus pneumoniae; Invasive pneumococcal disease (IPD); Risk conditions; CONJUGATE VACCINE; STREPTOCOCCUS-PNEUMONIAE; UNITED-STATES; EPIDEMIOLOGY; CHILDREN; ERA; INFECTIONS;

D O I：

10.1016/j.vaccine.2016.07.003

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Purpose: In the United States, the 13-valent pneumococcal conjugate vaccine is recommended in persons 65 years of age, and persons <= 65 years of age with immunocompromising (IC) conditions. For invasive pneumococcal disease (IPD) prevention in those <= 65 with non-IC medical conditions, the 23-valent polysaccharide vaccine is recommended. This group is at higher risk of IPD than the general population, but the level of risk is not well-quantified. We estimated IPD risk by individual underlying medical conditions, and by total number of conditions, for persons 18 years of age. We calculated the relative risks (RR) of various medical conditions, comparing the incident IPD cases to the general study population, and used Poisson regression models to estimate an IPD RR, adjusting for other conditions. We also examined IPD incidence by number of conditions diagnosed in each calendar year, using a risk-stacking model. Results: Underlying medical conditions with the highest adjusted RR for IPD were chronic liver disease (RR 2.1, 95% CI 1.5-2.8) and chronic obstructive pulmonary disease (COPD; RR 2.1, 95% CI 1.8-2.5). IPD risk increased with increasing number of medical conditions: adjusted RR, 2.2 (95% CI 1.9-2.5) 1 condition, 2.9 (2.5-3.5) for 2 conditions, and 5.2 (4.4-6.1) for 3 conditions. Conclusions: For persons with a single, non-IC medical condition, IPD risk was twice that for the general KPNC population. Persons with multiple, non-IC chronic conditions exhibited increased IPD risk with each additional condition. Such information may inform discussions on recommendations for adult pneumococcal immunization and prevention. (C) 2016 Elsevier Ltd. All rights reserved.

引用

页码：4293 / 4297

页数：5

共 16 条

[1] The Changing Epidemiology of Invasive Pneumococcal Disease at a Tertiary Children's Hospital Through the 7-valent Pneumococcal Conjugate Vaccine Era A Case for Continuous Surveillance [J].

Ampofo, Krow ;

Pavia, Andrew T. ;

Stockmann, Chris ;

Hersh, Adam L. ;

Bender, Jeffrey M. ;

Blaschke, Anne J. ;

Weng, Hsin Yi Cindy ;

Korgenski, Kent E. ;

Daly, Judy ;

Mason, Edward O. ;

Byington, Carrie L. .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (03) :228-234

[2] Redefining risk categories for pneumococcal disease in adults: critical analysis of the evidence [J].

Curcio, Daniel ;

Cane, Alejandro ;

Isturiz, Raul .

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2015, 37 :30-35

[3]

Demczuk WHB, 2012, CAN J MICROBIOL, V58, P1008, DOI [10.1139/w2012-073, 10.1139/W2012-073]

[4] Socioeconomic risk factors for bacteraemic pneumococcal pneumonia in adults [J].

Flory, J. H. ;

Joffe, M. ;

Fishman, N. O. ;

Edelstein, P. H. ;

Metlay, J. P. .

EPIDEMIOLOGY AND INFECTION, 2009, 137 (05) :717-726

[5] Nearly Complete Elimination of the 7-valent Pneumococcal Conjugate Vaccine Serotypes in Tennessee [J].

Halasa, Natasha B. ;

Grijalva, Carlos G. ;

Arbogast, Patrick G. ;

Talbot, Thomas R. ;

Craig, Allen S. ;

Griffin, Marie R. ;

Schaffner, William .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2013, 32 (06) :604-609

[6] Early Trends for Invasive Pneumococcal Infections in Children After the Introduction of the 13-valent Pneumococcal Conjugate Vaccine [J].

Kaplan, Sheldon L. ;

Barson, William J. ;

Lin, Philana Ling ;

Romero, Jose R. ;

Bradley, John S. ;

Tan, Tina Q. ;

Hoffman, Jill A. ;

Givner, Laurence B. ;

Mason, Edward O., Jr. .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2013, 32 (03) :203-207

[7] Have changing pneumococcal vaccination programmes impacted disease in Ontario? [J].

Lim, Gillian H. ;

Wormsbecker, Anne E. ;

McGeer, Allison ;

Pillai, Dylan R. ;

Gubbay, Jonathan B. ;

Rudnick, Wallis ;

Low, Don E. ;

Green, Karen ;

Crowcroft, Natasha S. ;

Deeks, Shelley L. .

VACCINE, 2013, 31 (24) :2680-2685

[8] Epidemiology of Pneumococcal Disease in a National Cohort of Older Adults [J].

Morrill H.J. ;

Caffrey A.R. ;

Noh E. ;

LaPlante K.L. .

Infectious Diseases and Therapy, 2014, 3 (1) :19-33

[9]

Muhammad Riyadh D, 2013, Clin Infect Dis, V56, pe59, DOI 10.1093/cid/cis971

[10] Risk of Pneumococcal Disease in Children With Chronic Medical Conditions in the Era of Pneumococcal Conjugate Vaccine [J].

Pelton, Stephen I. ;

Weycker, Derek ;

Farkouh, Raymond A. ;

Strutton, David R. ;

Shea, Kimberly M. ;

Edelsberg, John .

CLINICAL INFECTIOUS DISEASES, 2014, 59 (05) :615-623

← 1 2 →